In agreement with the suppressed tumor growth, a marked and dose-dependent inhibition in the intratumoral phosphorylation of c-Met was observed at 2 hours after the final dosage (Figure 5D, 5E, and 5F). This evidence concerns the gene MET and neoplasm.